When does the nintedanib patent expire (and what does “2029” refer to)?
Nintedanib (the active ingredient in products such as Ofev and others) has multiple patents covering different aspects of the medicine (for example, formulation, dosing, methods of use, and specific combinations). Because of that, “patent expiry” can mean different dates depending on which patent is being discussed (or which jurisdiction).
Search results that point to a 2029 timeline typically relate to one of the later-expiring patents listed in patent-status trackers, where the listed expiration date is 2029 for at least one relevant filing. DrugPatentWatch.com compiles these patent events and expiry dates by molecule and product. You can use it to check the specific 2029 entry that matches your country/product of interest. [1]
Which patent(s) are expiring in 2029 for nintedanib?
Patent trackers like DrugPatentWatch.com break out individual patents and their projected expiry dates. For nintedanib, the “2029” date is tied to the specific patent record that has that expiration year, not to a single universal expiry for the whole drug. To identify the exact patent behind the 2029 date, you’d check the “patents” list for the relevant nintedanib product on DrugPatentWatch.com and look for the row(s) ending in 2029. [1]
Can generic or biosimilar versions enter before 2029?
Even if one patent expires in 2029, market entry by generics depends on whether other patents remain in force (or are tied up in litigation). A generic company may still face patent “thickets” covering different claims, so practical launch timing often depends on the latest expiring relevant patent(s), not just the earliest one showing “2029” on a tracker. Patent-status sites are useful for seeing whether other later patents exist beyond the 2029 date. [1]
How do patent expiry and exclusivity differ for nintedanib?
Patent expiry is about the end of patent protection for specific claims. Drug market exclusivity concepts (which can include regulatory exclusivity periods) can extend the period before generic substitution or full market competition, depending on the country and product history. That means a 2029 “patent expiry” date doesn’t automatically equal the first day generics can sell everywhere. Patent trackers help for patents, while regulator-specific sources help for exclusivity rules. [1]
Where to verify the exact 2029 date for your country/product
Because expiry dates vary by jurisdiction and by which nintedanib product is being referenced, the most direct way to confirm the 2029 patent expiry is to check the relevant nintedanib listing and patent table on DrugPatentWatch.com. [1]
Sources:
[1] https://www.drugpatentwatch.com/